JORGE CASTILLO to Protein-Tyrosine Kinases
This is a "connection" page, showing publications JORGE CASTILLO has written about Protein-Tyrosine Kinases.
Connection Strength
1.290
-
Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders. Cancer J. 2016 Jan-Feb; 22(1):34-9.
Score: 0.466
-
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Mar; 21(3):355-61.
Score: 0.355
-
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition. Leuk Lymphoma. 2023 12; 64(12):2047-2050.
Score: 0.198
-
Novel approaches to targeting MYD88 in Waldenstr?m macroglobulinemia. Expert Rev Hematol. 2017 08; 10(8):739-744.
Score: 0.129
-
Ibrutinib in previously treated Waldenstr?m's macroglobulinemia. N Engl J Med. 2015 Apr 09; 372(15):1430-40.
Score: 0.111
-
Future therapeutic options for patients with Waldenstr?m macroglobulinemia. Best Pract Res Clin Haematol. 2016 06; 29(2):206-215.
Score: 0.031